- 
             Something wrong with this record ?
 
In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments
G. Mestres, MA. Fernandez-Yague, D. Pastorino, EB. Montufar, C. Canal, MC. Manzanares-Céspedes, MP. Ginebra,
Language English Country Netherlands
Document type Journal Article
- MeSH
- Anti-Bacterial Agents administration & dosage pharmacokinetics pharmacology MeSH
- Doxycycline administration & dosage pharmacology MeSH
- Femur diagnostic imaging pathology MeSH
- Calcium Phosphates chemistry MeSH
- Drug Implants chemistry pharmacology MeSH
- Bone Diseases, Infectious drug therapy therapy MeSH
- Bone Cements chemistry pharmacology MeSH
- Rabbits MeSH
- Drug Delivery Systems methods MeSH
- Osteomyelitis drug therapy therapy MeSH
- Porosity MeSH
- Bone Regeneration drug effects MeSH
- Staphylococcal Infections drug therapy therapy MeSH
- Drug Liberation MeSH
- Viscoelastic Substances chemistry MeSH
- Treatment Outcome MeSH
- Animals MeSH
- Check Tag
- Rabbits MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The purpose of the present work was to evaluate in vivo different antimicrobial therapies to eradicate osteomyelitis created in the femoral head of New Zealand rabbits. Five phosphate-based cements were evaluated: calcium phosphate cements (CPC) and calcium phosphate foams (CPF), both in their pristine form and loaded with doxycycline hyclate, and an intrinsic antimicrobial magnesium phosphate cement (MPC; not loaded with an antibiotic). The cements were implanted in a bone previously infected with Staphylococcus aureus to discern the effects of the type of antibiotic administration (systemic vs. local), porosity (microporosity, i.e. <5 μm vs. macroporosity, i.e. >5 μm) and type of antimicrobial mechanism (release of antibiotic vs. intrinsic antimicrobial activity) on the improvement of the health state of the infected animals. A new method was developed, with a more comprehensive composite score that integrates 5 parameters of bone infection, 4 parameters of bone structural integrity and 4 parameters of bone regeneration. This method was used to evaluate the health state of the infected animals, both before and after osteomyelitis treatment. The results showed that the composite score allows to discern statistically significant differences between treatments that individual evaluations were not able to identify. Despite none of the therapies completely eradicated the infection, it was observed that macroporous materials (CPF and CPFd, the latter loaded with doxycycline hyclate) and intrinsic antimicrobial MPC allowed a better containment of the osteomyelitis. This study provides novel insights to understand the effect of different antimicrobial therapies in vivo, and a promising comprehensive methodology to evaluate the health state of the animals was developed. We expect that the implementation of such methodology could improve the criteria to select a proper antimicrobial therapy.
CEITEC Central European Institute of Technology Brno University of Technology Brno Czech Republic
Growth factors and cellular differenciation L'Hospitalet de Llobregat Barcelona Spain
Institute of Bioengineering of Catalonia Baldiri i Reixach 10 12 08028 Barcelona Spain
Research Centre in Multiscale Science and Engineering UPC Barcelona Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027876
- 003
- CZ-PrNML
- 005
- 20190816111540.0
- 007
- ta
- 008
- 190813s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.msec.2018.11.064 $2 doi
- 035 __
- $a (PubMed)30678975
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mestres, G $u Department of Engineering Sciences, Science for Life Laboratory, Uppsala University, Box 534, 751 21 Uppsala, Sweden.
- 245 10
- $a In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments / $c G. Mestres, MA. Fernandez-Yague, D. Pastorino, EB. Montufar, C. Canal, MC. Manzanares-Céspedes, MP. Ginebra,
- 520 9_
- $a The purpose of the present work was to evaluate in vivo different antimicrobial therapies to eradicate osteomyelitis created in the femoral head of New Zealand rabbits. Five phosphate-based cements were evaluated: calcium phosphate cements (CPC) and calcium phosphate foams (CPF), both in their pristine form and loaded with doxycycline hyclate, and an intrinsic antimicrobial magnesium phosphate cement (MPC; not loaded with an antibiotic). The cements were implanted in a bone previously infected with Staphylococcus aureus to discern the effects of the type of antibiotic administration (systemic vs. local), porosity (microporosity, i.e. <5 μm vs. macroporosity, i.e. >5 μm) and type of antimicrobial mechanism (release of antibiotic vs. intrinsic antimicrobial activity) on the improvement of the health state of the infected animals. A new method was developed, with a more comprehensive composite score that integrates 5 parameters of bone infection, 4 parameters of bone structural integrity and 4 parameters of bone regeneration. This method was used to evaluate the health state of the infected animals, both before and after osteomyelitis treatment. The results showed that the composite score allows to discern statistically significant differences between treatments that individual evaluations were not able to identify. Despite none of the therapies completely eradicated the infection, it was observed that macroporous materials (CPF and CPFd, the latter loaded with doxycycline hyclate) and intrinsic antimicrobial MPC allowed a better containment of the osteomyelitis. This study provides novel insights to understand the effect of different antimicrobial therapies in vivo, and a promising comprehensive methodology to evaluate the health state of the animals was developed. We expect that the implementation of such methodology could improve the criteria to select a proper antimicrobial therapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x farmakokinetika $x farmakologie $7 D000900
- 650 _2
- $a kostní cementy $x chemie $x farmakologie $7 D001843
- 650 _2
- $a infekční nemoci kostí $x farmakoterapie $x terapie $7 D001850
- 650 _2
- $a regenerace kostí $x účinky léků $7 D001861
- 650 _2
- $a fosforečnany vápenaté $x chemie $7 D002130
- 650 _2
- $a doxycyklin $x aplikace a dávkování $x farmakologie $7 D004318
- 650 _2
- $a lékové transportní systémy $x metody $7 D016503
- 650 _2
- $a implantované léky $x chemie $x farmakologie $7 D004343
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a femur $x diagnostické zobrazování $x patologie $7 D005269
- 650 _2
- $a osteomyelitida $x farmakoterapie $x terapie $7 D010019
- 650 _2
- $a poréznost $7 D016062
- 650 _2
- $a králíci $7 D011817
- 650 _2
- $a stafylokokové infekce $x farmakoterapie $x terapie $7 D013203
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a viskoelastické látky $x chemie $7 D055682
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fernandez-Yague, M A $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain.
- 700 1_
- $a Pastorino, D $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain.
- 700 1_
- $a Montufar, E B $u CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
- 700 1_
- $a Canal, C $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain.
- 700 1_
- $a Manzanares-Céspedes, M C $u Human Anatomy and Embryology Unit, University of Barcelona, Faculty of Medicine and Health Sciences, Barcelona, Spain; Growth factors and cellular differenciation (Bellvitge Biomedical Research Institute, IDIBELL) L'Hospitalet de Llobregat, Barcelona, Spain.
- 700 1_
- $a Ginebra, M P $u Biomaterials, Biomechanics and Tissue Engineering Group, Dpt. Materials Science and Metallurgy, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain; Research Centre in Multiscale Science and Engineering, UPC, Barcelona, Spain; Institute of Bioengineering of Catalonia (IBEC), Baldiri i Reixach 10-12, 08028 Barcelona, Spain. Electronic address: maria.pau.ginebra@upc.edu.
- 773 0_
- $w MED00184559 $t Materials science & engineering. C, Materials for biological applications $x 1873-0191 $g Roč. 97, č. - (2019), s. 84-95
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30678975 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816111810 $b ABA008
- 999 __
- $a ok $b bmc $g 1433025 $s 1066336
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 97 $c - $d 84-95 $e 20181128 $i 1873-0191 $m Materials science & engineering. C, Materials for biological applications $n Mater Sci Eng C Mater Biol Appl $x MED00184559
- LZP __
- $a Pubmed-20190813
